Citation: Rf. Lyons et al., AN ANALYSIS OF DRUG INFORMATION DESIRED BY THE PATIENT - (ARE PATIENTS BEING TOLD EVERYTHING THEY WISH TO KNOW UNDER OBRA-90), Journal of clinical pharmacy and therapeutics, 21(4), 1996, pp. 221-228
Citation: J. Tomaszewski et Mm. Rumore, STEREOISOMERIC DRUGS - FDAS POLICY STATEMENT AND THE IMPACT ON DRUG DEVELOPMENT, Drug development and industrial pharmacy, 20(2), 1994, pp. 119-139
Citation: Ma. Goldwire et Mm. Rumore, SOURCES OF REGULATORY INFORMATION FOR PHARMACISTS, American journal of hospital pharmacy, 50(6), 1993, pp. 1175-1181